Seeing Is Believing
Currently out of the existing stock ratings of Roanna Ruiz, 62 are a BUY (66.67%), 31 are a HOLD (33.33%).
Analyst Roanna Ruiz, carries an average stock price target met ratio of 45.99% that have a potential upside of 37.56% achieved within 188 days.
Roanna Ruiz’s has documented 175 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on XERS, Xeris Pharmaceuticals at 09-Sep-2026.
Analyst best performing recommendations are on SCPH (SCPHARMACEUTICALS).
The best stock recommendation documented was for SCPH (SCPHARMACEUTICALS) at 9/9/2021. The price target of $6 was fulfilled within 1 day with a profit of $0.17 (2.76%) receiving and performance score of 27.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2026
$27
$16.97 (169.19%)
$24
3 months 27 days ago
(11-Jun-2026)
0/5 (0%)
$18.48 (216.90%)
Buy Since 14-Sep-2022
$21
$10.97 (109.37%)
$20
4 months 5 days ago
(03-Jun-2026)
0/6 (0%)
$12.23 (139.45%)
Buy Since 21-Sep-2020
$20
$9.97 (99.40%)
$15
7 months 4 days ago
(04-Mar-2026)
1/9 (11.11%)
$10.44 (109.21%)
128
Buy Since 11-Mar-2021
$18
$7.97 (79.46%)
$14
7 months 14 days ago
(24-Feb-2026)
0/19 (0%)
$8.51 (89.67%)
Buy Since 03-Sep-2025
$18
$7.97 (79.46%)
$12
7 months 14 days ago
(24-Feb-2026)
0/2 (0%)
$8.51 (89.67%)
Which stock is Roanna Ruiz most bullish on?
Which stock is Roanna Ruiz most reserved on?